NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological ...
Vigil Neuroscience is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel ...
WATERTOWN, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ...
Please provide your email address to receive an email when new articles are posted on . In this video, Alokkumar Jha, PhD, MSc, BE, spoke with Healio about key presentations from the American ...
(MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) ...
Sangamo Therapeutics (NASDAQ:SGMO) presented its Q2 2025 corporate update on August 7, highlighting its strategic focus on neurology-based genomic medicines while facing significant financial ...
RESTON, Va., Jan. 28, 2020 /PRNewswire/ -- SOC Telemed (SOC), the leader in acute care telemedicine, today commemorates accomplishments from the SOC Neurology Leadership Council's inaugural year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results